Nicotinic- and muscarinic-evoked release of canine adrenal catecholamines and peptides.
The tissue content and overflow of norepinephrine (NE), epinephrine (Epi), dopamine (DA), Met-enkephalin (Met-Enk), and neuropeptide Y (NPY) from isolated, retrogradely perfused dog adrenal glands were studied. Under resting conditions, approximately 25% of the overflow of autocoids from the glands was Ca2+ dependent; the cholinergic antagonists hexamethonium and atropine had no effects on basal efflux. Stimulation with the nicotinic agonist 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP; 3 or 50 microM) or with the muscarinic agonist pilocarpine (50 microM or 1 mM) evoked releases of autocoids. These releases were blocked or dramatically reduced by appropriate antagonists or by the removal of Ca2+ from the perfusate. Expressed as percentages of tissue stores, the rank order of overflow of autocoids was E approximately DA much greater than NE during resting conditions, DA much greater than E approximately NE during stimulation with 50 microM DMPP, and DA greater than Epi greater than NE during stimulation with 1 mM pilocarpine. These data are consistent with different mechanisms of release for the catecholamines, perhaps from different cell populations. The data support corelease of peptides and catecholamines, although clear pairing of autocoids could not be confirmed.
Chritton
S L
SL
Department of Physiology, Mayo Clinic, Rochester, Minnesota 55905.
Dousa
M K
MK
Yaksh
T L
TL
Tyce
G M
GM
D000311:Adrenal Glands / Q000378:metabolism*; D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005731:Ganglionic Stimulants / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D009479:Neuropeptides / Q000378:metabolism*; D010277:Parasympathomimetics / Q000494:pharmacology*; D010477:Perfusion; D010862:Pilocarpine / Q000494:pharmacology; D012016:Reference Values
D002395:Catecholamines; D005731:Ganglionic Stimulants; D009479:Neuropeptides; D010277:Parasympathomimetics; D010862:Pilocarpine; D004246:Dimethylphenylpiperazinium Iodide